Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

BrainCool AB Company Overview 4

BrainCool AB Company Snapshot 4

BrainCool AB Pipeline Products and Ongoing Clinical Trials Overview 4

BrainCool AB – Pipeline Analysis Overview 7

BrainCool AB - Key Facts 7

BrainCool AB - Major Products and Services 8

BrainCool AB Pipeline Products by Development Stage 9

BrainCool AB Ongoing Clinical Trials by Trial Status 11

BrainCool AB Pipeline Products Overview 13

Cooral System 13

Cooral System Product Overview 13

Cooral System Clinical Trial 14

IQool System 15

IQool System Product Overview 15

PolarCap System - Concussion 16

PolarCap System - Concussion Product Overview 16

RhinoChill IntraNasal Cooling System 17

RhinoChill IntraNasal Cooling System Product Overview 17

RhinoChill IntraNasal Cooling System Clinical Trial 18

BrainCool AB - Key Competitors 19

BrainCool AB - Key Employees 20

BrainCool AB - Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

BrainCool AB, Recent Developments 22

May 29, 2018: European Medical Device Firm BrainCool Receives New 510(k) Clearance from FDA for IQool Warm System for Temperature Modulation 22

Nov 16, 2017: BrainCool Establishes US Headquarters and Adds Bryan Nicholson as VP Operations 22

Nov 16, 2017: European Medical Device Firm BrainCool Establishes US Headquarters and Adds Bryan Nicholson as VP Operations 23

Sep 04, 2017: BrainCool obtains US patent approval 23

May 17, 2017: European Medical Device Firm BrainCool Enters US Market with 510(k) Clearance from FDA for IQool System for Temperature Management 24

Mar 27, 2017: Regulatory breakthrough in the US for RhinoChill migraine 24

Nov 10, 2016: BrainCool Clinical trial agreement with Center for Resuscitation Science at Karolinska Institute and dep. of cardiology Sodersjukhuset in Sweden 25

Oct 07, 2016: New revolutionary stroke treatment – safety and tolerability of therapeutic cooling confirmed in a pan-European clinical trial 26

Jun 11, 2015: Insight into BeneChill’s Proprietary Intra Nasal Cooling System Details on the RhinoChill System 27

Jun 02, 2015: Nasal Cavity Cooling for Migraine Trial, Utilizing BeneChill’s Proprietary Cooling System, Wins NHS’s 12th Bright Ideas in Health Awards 27

Appendix 29

Methodology 29

About GlobalData 32

Contact Us 32

Disclaimer 32

Summary

BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contributes considerably to improved survival after an episode of cardiac arrest. The company’s product portfolio comprises BrainCool system for stroke and cardiac arrest; and the Cooral System for prevention of oral mucositis. It also offers IQool warm system, a thermoregulatory device to monitor and control patient temperature through its anatomically-targeted temperature regulation pads. The company commercializes its products in Europe and the US. BrainCool is headquartered in Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BrainCool AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company